| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $85.86 | $24.54 | 249.94% | 162.00x | 40.86x | 10.89x | 13.15x | 1.17x | $106.92M | 1.18% | $705.78M | 6.70 | $9.18B | 1,170.14 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $31.20 | $8.41 | 270.90% | 148.57x | 70.83x | 8.78x | 17.78x | 1.27x | $39.15M | 0.96% | $220.58M | 1.69 | $4.00B | 88.15 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $224.03 | $84.69 | 164.52% | 36.73x | 33.74x | 6.23x | 22.14x | 1.21x | $793.95M | 2.65% | $1.35B | 10.14 | $31.26B | 26.50 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $76.73 | $17.70 | 333.43% | 71.71x | 65.64x | 7.08x | 9.15x | 1.83x | $182.84M | 3.07% | $654.15M | 8.43 | $5.82B | 48.52 | ||
| RPRX | ROYALTY PHARMA PLC | $63.86 | $37.04 | 72.43% | 33.97x | 11.75x | 11.21x | 3.75x | 0.68x | $2.92B | 10.29% | $9.79B | 21.99 | $44.87B | 38.15 | ||
| HALO | HALOZYME THERAPEUTICS INC | $125.63 | $73.07 | 71.93% | 35.29x | 13.88x | 8.86x | 99.33x | 0.67x | $806.22M | 5.47% | $143.54M | 1.22 | $16.24B | 22.61 | ||
| KRYS | KRYSTAL BIOTECH INC | $311.50 | $85.07 | 266.17% | 37.67x | 40.52x | 20.88x | 6.78x | 2.04x | $257.78M | 2.80% | $1.36B | 46.03 | $8.80B | 37.73 | ||
| VCEL | VERICEL CORP | $42.53 | $8.16 | 421.34% | 88.60x | 75.99x | 7.09x | 5.89x | 2.17x | $61.66M | 2.84% | $370.04M | 7.25 | $2.14B | 48.70 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.95 | $19.18 | 191.77% | 147.24x | 20.29x | 3.18x | 1.71x | 0.97x | $738.18M | 6.82% | $6.32B | 32.68 | $14.14B | 36.67 | ||
| ADMA | ADMA BIOLOGICS INC | $10.68 | $7.12 | 50.00% | 14.83x | 13.42x | 4.76x | 5.86x | 0.86x | $116.47M | 4.78% | $408.21M | 1.79 | $2.45B | 10.53 | ||
| TGTX | TG THERAPEUTICS INC | $54.17 | $23.52 | 130.36% | 17.59x | 54.03x | 9.60x | 13.73x | 1.82x | $17.39M | 0.23% | $604.08M | 4.26 | $8.56B | 61.49 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $214.00 | $184.93 | 15.72% | 14.02x | 8.96x | 2.94x | 2.89x | 0.57x | $1.62B | 11.97% | $4.80B | 75.98 | $16.67B | 10.31 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $303.53 | $88.11 | 244.48% | 30.14x | 32.14x | 20.96x | 6.25x | 2.25x | $130.62M | 2.15% | $967.52M | 48.22 | $6.18B | 22.14 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.81 | $7.77 | 26.32% | 10.33x | 9.02x | 4.27x | 2.68x | 0.90x | $82.01M | 14.13% | $217.65M | 3.68 | $438.73M | 5.67 | ||
| MDXG | MIMEDX GROUP INC | $3.91 | $1.23 | 217.68% | 97.75x | -21.70x | 1.63x | 2.64x | 1.13x | $44.50M | 7.70% | $216.00M | 1.46 | $451.29M | 19.79 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $523.93 | $151.30 | 246.28% | 30.23x | 27.43x | 10.56x | 6.56x | 2.27x | $3.80B | 2.86% | $20.25B | 79.81 | $128.63B | 23.37 | ||
| EXEL | EXELIXIS INC | $64.53 | $31.24 | 106.57% | 19.61x | 19.38x | 6.64x | 8.67x | 1.24x | $1.17B | 7.24% | $1.84B | 7.35 | $15.87B | 14.59 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.13 | $31.48 | 14.78% | 11.51x | 8.67x | 2.18x | 2.11x | 0.65x | $354.90M | 16.96% | $999.24M | 17.25 | $1.71B | 6.10 | ||
| UTHR | UNITED THERAPEUTICS CORP | $587.50 | $192.34 | 205.44% | 19.43x | 21.73x | 7.93x | 3.94x | 3.57x | $1.09B | 4.37% | $6.40B | 150.24 | $23.40B | 13.95 | ||
| TECH | BIO-TECHNE CORP | $72.55 | $16.65 | 335.87% | 62.01x | 34.92x | 9.31x | 5.40x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.40B | 32.79 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $805.02 | $438.24 | 83.70% | 19.19x | 13.78x | 5.33x | 2.61x | 1.01x | $3.76B | 4.54% | $31.71B | 308.48 | $83.13B | 14.46 | ||
| VCYT | VERACYTE INC | $47.93 | $12.16 | 294.21% | 33.28x | 24.65x | 6.82x | 2.78x | 2.69x | $165.99M | 4.33% | $1.39B | 17.36 | $3.59B | 25.72 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.11 | $1.42 | -21.63% | 7.93x | -2.50x | 1.37x | 1.46x | 0.44x | $19.58M | 30.45% | $44.20M | 0.76 | $15.91M | 2.08 | ||
| INCY | INCYTE CORP | $115.71 | $58.80 | 96.80% | 14.25x | 34.42x | 3.98x | 3.70x | 1.70x | $1.92B | 8.28% | $6.34B | 31.66 | $19.50B | 9.43 |